-
'Widow's Bay' and 'The Pitt' are favorites for Emmys night
-
DR Congo school fire stampede death toll rises to 26: UNICEF
-
'Everything different' as Zverev returns to US Open final
-
Coastal erosion forces cancellation of California music festival
-
Top seed Zverev holds off Khachanov to reach US Open final
-
Anthropic says UAE-linked AI op targeted UN experts over Sudan
-
James McAvoy brings new film 'Faith' to Toronto fest
-
Rennes beat Marseille to seize top spot in Ligue 1
-
Faultless Duplantis, hungry Ingebrigtsen shine at inaugural Ultimate
-
Duplantis delivers masterclass for Ultimate pole vault win
-
Roblox to launch wallet to pay creators faster and will allow off-platform gaming
-
Weapons, spyware and AI scams: Anthropic exposes Claude misuse
-
Springboks wary of new-look All Blacks in Baltimore test
-
Gary Oldman hopes Jack Lowden is the new James Bond
-
Townsend, Siniakova win US Open doubles for career Grand Slam together
-
Six-stop race is best on tyre-shredding Madrid track says Russell
-
Verstappen unimpressed with new Madrid street track
-
Prosecutors seek up to 10 years prison over violent burglary of Donnarumma
-
Razaullah heroics deny England quickfire win in 3rd Test against Pakistan
-
Solheim Cup on a knife-edge after Korda record
-
Masks banned at planned UK protests: police
-
Corruption probe targets Brazil presidential candidate Flavio Bolsonaro
-
Antonelli on top ahead of Ferraris in Madrid practice
-
New No.1 Rybakina out to thwart Sabalenka US Open three-peat bid
-
Dance Fitness Tempe Announces Expansion of Accessible Digital Movement Programs
-
US marks 25th anniversary of 9/11 attacks
-
Nashville airport to be renamed after Dolly Parton
-
'That's why we fight': Trump links 9/11 to Iran conflict
-
Argentina's Dirty War rears its head in Venice film
-
Europe saw record summer air traffic despite Mideast war: Eurocontrol
-
'Whatever we do is political' says Iranian director Asgari at Venice
-
De Zerbi coy over unsettled Richarlison's Spurs future
-
UK lawmakers throw out bill to legalise assisted dying
-
Brazil president candidate Flavio Bolsonaro targeted in corruption probe
-
Relatives of 9/11 victims hit out at Saudi Arabia -- and US leaders
-
England dismiss Pakistan's Masood to close on victory in 3rd Test
-
Egyptian teenager Abdelkarim to extend Barca deal to 2030
-
Oil prices, US inflation stoke Fed hike worries
-
Macau to hold closed-door trial in first national security case
-
Free-scoring Chelsea must tighten up, says Alonso
-
Philippines recovers 30 bodies from ferry after blaze
-
US inflation steady in August, fueling Fed rate hike expectations
-
Relative of 9/11 victim unleashes searing attack on Saudi Arabia
-
United boss Carrick dismisses Anderson's 'kings of Manchester' jibe
-
Russell edges Antonelli in accident-free opening practice in Madrid
-
New York marks 25th anniversary of 9/11 attacks
-
Sweden's outgoing PM wants to 'make Sweden great again'
-
Yemen's Houthis take over strait vital to global shipping
-
Fenced off: Thailand builds border wall after Cambodia clashes
-
Russia rolls out long-delayed 5G, but not for iPhones
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
P.Martin--AMWN